New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on: January 12,2024

New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on:January 12,2024

Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients: Study

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainRegular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome

Updated on: May 27,2024

Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients: Study

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainRegular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome

Updated on:May 27,2024

Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates

by Society of Nuclear Medicine and Molecular ImagingSummary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiat

Updated on: January 15,2024

Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates

by Society of Nuclear Medicine and Molecular ImagingSummary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiat

Updated on:January 15,2024

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

by Inka Väth,University Hospital of BonnGraphical abstract. Credit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.09.002The genetic confirmation of a suspecte

Updated on: November 10,2024

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

by Inka Väth,University Hospital of BonnGraphical abstract. Credit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.09.002The genetic confirmation of a suspecte

Updated on:November 10,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on: February 20,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on:February 20,2024

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on: January 29,2024

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on:January 29,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on: January 29,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on:January 29,2024

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024

Research shows effectiveness of new technique to detect ovarian cancer marker peptides

by Brian McNeill,Virginia Commonwealth UniversityVCU physics doctoral candidates Mohammed Almahyawi and Thomas W. Rockett demonstrate the setup of their nanopore research that could one day help

Updated on: March 05,2024

Research shows effectiveness of new technique to detect ovarian cancer marker peptides

by Brian McNeill,Virginia Commonwealth UniversityVCU physics doctoral candidates Mohammed Almahyawi and Thomas W. Rockett demonstrate the setup of their nanopore research that could one day help

Updated on:March 05,2024

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on: January 22,2024

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on:January 22,2024

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on: March 01,2024

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on:March 01,2024

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on: January 12,2024

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on:January 12,2024